Aggressive presentation of plasmablastic myeloma

BMJ Case Rep. 2020 Apr 6;13(4):e234436. doi: 10.1136/bcr-2020-234436.

Authors

Jaime Andres Suarez-Londono¹, Abhinav Rohatgi¹, Crystal Antoine-Pepeljugoski¹, Marc J Braunstein²

Affiliations

¹ Department of Medicine, Division of Oncology-Hematology, NYU Long Island School of Medicine, NYU Winthrop Hospital, Mineola, New York, USA.
² Department of Medicine, Division of Oncology-Hematology, NYU Long Island School of Medicine, NYU Winthrop Hospital, Mineola, New York, USA [email protected].

No abstract available

Keywords: haematology (incl blood transfusion); malignant disease and immunosuppression; oncology.

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal / therapeutic use
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Biopsy
Bone Marrow / pathology
Fatal Outcome
Humans
Immunoglobulin lambda-Chains / immunology
Immunosuppressive Agents / therapeutic use
Male
Middle Aged
Multiple Myeloma / immunology
Multiple Myeloma / pathology*
Multiple Myeloma / therapy
Neoplasm Metastasis / diagnostic imaging
Neoplasm Metastasis / pathology
Plasma Cells / immunology
Plasma Cells / pathology*
Positron Emission Tomography Computed Tomography / methods*
Spinal Neoplasms / diagnostic imaging
Spinal Neoplasms / pathology
Spinal Neoplasms / radiotherapy
Testis / pathology

Substances

Antibodies, Monoclonal
Immunoglobulin lambda-Chains
Immunosuppressive Agents